KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Joint (JYNT) Divestments (2024 - 2025)

Joint (JYNT) has disclosed Divestments for 2 consecutive years, with $7.7 million as the latest value for Q2 2025.

Quarterly Divestments rose 4347.23% to $7.7 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, up 1303.77% year-over-year, with the annual reading at $7.8 million for FY2025, 1303.77% up from the prior year.
Divestments hit $7.7 million in Q2 2025 for Joint, up from $40100.0 in the prior quarter.
In the past five years, Divestments ranged from a high of $7.7 million in Q2 2025 to a low of $40100.0 in Q1 2025.